Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancer
Associate Professor Eunah Kang and Mr. Youngjun Kim from the [...]
First Participant Treated at the Highest Dose Level in Clarity’s Theranostic Prostate Cancer Trial
Clarity’s Executive Chairperson, Dr Alan Taylor, commented, “Results from cohort 2 [...]
AI Therapeutics Announces Investigator Initiated Phase 2 Trial at UCSF to Study LAM-001 in Patients With Bronchiolitis Obliterans Syndrome (BOS) Post-Lung Transplant
LAM-001 is a proprietary, investigational, inhaled formulation of sirolimus, also [...]
New Study Demonstrates Ropeginterferon Alfa-2b-njft Is a Cost-Effective Treatment Option for a Broad Range of Patients with Polycythemia Vera
Polycythemia vera (PV) is a cancer originating from a disease-initiating [...]
HiFiBiO Therapeutics Announces First Patient Dosed with HFB200301 in Combination with tislelizumab in Patients with DIS® Selected Advanced Solid Tumors
Liang Schweizer, PhD, Founder, CEO, and Chairperson of HiFiBiO Therapeutics, [...]
Sorrento Therapeutics, Inc. announces a $4.6 Million U.S. Government Contract from the NIAID for a Sensitive, Reusable, and Rapid Diagnostic Platform for Pandemic Preparedness
“We are pleased to accept this award and collaboration with [...]
Adaptive Phage Therapeutics Closes on $12 Million Investment in $30 Million Series B1 to Fight Antibiotic Resistant Infections
Greg Merril, co-Founder and CEO of Adaptive Phage Therapeutics: “This [...]
New Data Show Genentech’s Subcutaneously Administered Crovalimab Achieved Disease Control and Was Well-Tolerated in People With Paroxysmal Nocturnal Hemoglobinuria (PNH)
“With the option for subcutaneous self-administration, crovalimab could help meet [...]
DxVx, Won the Governmental Project to Develop Diagnostic Sensor Kit for Adult Diseases
In this project, which will be carried out over three [...]
Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual Meeting
“At ASCO, we are reporting early clinical data for three [...]